Physician profile
Michelle Leitheiser
NPI 1760071724
$329.52
in general payments reported to CMS, 2019-2025
7 companies · $19.02 in 2025
The $19.02 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.04 · 2022: $171 · 2023: $104 · 2024: $19.75 · 2025: $19.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $142.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $104.60 | 2022-2023 | Karbinal |
| Ironshore Pharmaceuticals INC. | $72.64 | 2022-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $58.56 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.68 | 2021-2022 | |
| Cranial Technologies, INC | $19.02 | 2025 | Doc Band |
| Neos Therapeutics, Lp | $14.98 | 2023 | Cotempla Xr-Odt |
| Pfizer INC. | $13.04 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Leitheiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.